Flyte Aviation, Inc. stock analysis VJET.US

Catheter Precision, Inc. primarily develops and sells medical devices for cardiac electrophysiology procedures. Its lead product, the VIVO system (short for View into Ventricular Onset), is a non‐invasive 3D cardiac mapping platform which assists physicians in localizing sites of origin of ventricular arrhythmias in patients with structurally normal hearts, prior to invasive procedures. Another significant product is LockeT, a suture retention device designed to temporarily secure sutures during closure procedures to aid clinicians in locating and removing them. The company also manufactures the Amigo Remote Catheter System, a robotic arm that allows remote catheter control during electrophysiology interventions.

Additional offerings include data acquisition, analysis, display and storage capabilities embedded in VIVO, which facilitate mapping and procedural planning. The VIVO system has obtained FDA clearance under product code DQK, classified as a Class II programmable diagnostic computer for use in cardiac mapping. Beyond electrophysiology, the product portfolio spans wound closure solutions (LockeT) and robotic support for catheter navigation (Amigo), reflecting a multi‐product strategy within the medical device domain.

Catheter Precision operates from its headquarters in Fort Mill, South Carolina, with regulatory representation in Europe via an authorized representative in Germany. Its markets include the United States and Europe, targeting hospitals, physicians, and clinical laboratories that perform cardiac arrhythmia diagnostics and ablation procedures. The company files regular reports with the U.S. Securities and Exchange Commission. Manufacturing, sales, and regulatory activities are aligned with medical device regulatory frameworks such as FDA and European Union standards.